Technology_banner_2.png

About Us

Management Team

CEO

Gibum Kim 

VP

Jaho Sohn

SJ Kim

Head of Global Business

Gibum worked in chemistry and bioscience for approximately 25 years. He was a research staff in Korea Electric Power Research Institution (KEPRI) for 7 years since 1993, leading the research project management of external participants.

He also worked as a scientist to Lumera Corporation and Beckman Coulter contributing to development of innovative technologies such as clinical diagnostic testing and microfluidics. In 2012, he founded Plexense, Inc. – a firm specialized in the development and production of immunoassay platform for clinical, food and life sciences.

 

 

Gibum earned a Master’s degree in analytical chemistry from Korea University in 1993 and a Ph.D. in chemistry from Texas A&M University.

 

Gibum worked in chemistry and bioscience for approximately 25 years. He was a research staff in Korea Electric Power Research Institution (KEPRI) for 7 years since 1993, leading the research project management of external participants.

He also worked as a scientist to Lumera Corporation and Beckman Coulter contributing to development of innovative technologies such as clinical diagnostic testing and microfluidics. In 2012, he founded Plexense, Inc. – a firm specialized in the development and production of immunoassay platform for clinical, food and life sciences.

 

 

Gibum earned a Master’s degree in analytical chemistry from Korea University in 1993 and a Ph.D. in chemistry from Texas A&M University.

 

Gibum worked in chemistry and bioscience for approximately 25 years. He was a research staff in Korea Electric Power Research Institution (KEPRI) for 7 years since 1993, leading the research project management of external participants.

He also worked as a scientist to Lumera Corporation and Beckman Coulter contributing to development of innovative technologies such as clinical diagnostic testing and microfluidics. In 2012, he founded Plexense, Inc. – a firm specialized in the development and production of immunoassay platform for clinical, food and life sciences.

 

 

Gibum earned a Master’s degree in analytical chemistry from Korea University in 1993 and a Ph.D. in chemistry from Texas A&M University.

 

JW Shin

Director

Lon Hatamiya

CEO of Plexense BIO

Kent Morgan

CSO of Plexense BIO

Gibum worked in chemistry and bioscience for approximately 25 years. He was a research staff in Korea Electric Power Research Institution (KEPRI) for 7 years since 1993, leading the research project management of external participants.

He also worked as a scientist to Lumera Corporation and Beckman Coulter contributing to development of innovative technologies such as clinical diagnostic testing and microfluidics. In 2012, he founded Plexense, Inc. – a firm specialized in the development and production of immunoassay platform for clinical, food and life sciences.

 

 

Gibum earned a Master’s degree in analytical chemistry from Korea University in 1993 and a Ph.D. in chemistry from Texas A&M University.

 

Gibum worked in chemistry and bioscience for approximately 25 years. He was a research staff in Korea Electric Power Research Institution (KEPRI) for 7 years since 1993, leading the research project management of external participants.

He also worked as a scientist to Lumera Corporation and Beckman Coulter contributing to development of innovative technologies such as clinical diagnostic testing and microfluidics. In 2012, he founded Plexense, Inc. – a firm specialized in the development and production of immunoassay platform for clinical, food and life sciences.

 

 

Gibum earned a Master’s degree in analytical chemistry from Korea University in 1993 and a Ph.D. in chemistry from Texas A&M University.

 

Gibum worked in chemistry and bioscience for approximately 25 years. He was a research staff in Korea Electric Power Research Institution (KEPRI) for 7 years since 1993, leading the research project management of external participants.

He also worked as a scientist to Lumera Corporation and Beckman Coulter contributing to development of innovative technologies such as clinical diagnostic testing and microfluidics. In 2012, he founded Plexense, Inc. – a firm specialized in the development and production of immunoassay platform for clinical, food and life sciences.

 

 

Gibum earned a Master’s degree in analytical chemistry from Korea University in 1993 and a Ph.D. in chemistry from Texas A&M University.